UNA S RYAN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for UNA S RYAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of UNA S RYAN. UNA S RYAN is President & CEO in Celldex Therapeutics, Inc. ($AVAN) and Director in ALBANY MOLECULAR RESEARCH INC ($AMRI) and Director in Cortexyme, Inc. ($CRTX).
Latest Insider Trading Transactions of UNA S RYAN
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRI, CLDX, CRTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 09 2020 | CRTX | Cortexyme, Inc. | RYAN UNA S | Director | Option Exercise | A | 41.73 | 11,029 | 460,240 | 11,029 | |
| Mar 12 2020 | CRTX | Cortexyme, Inc. | RYAN UNA S | Director | Buy | P | 17.00 | 2,875 | 48,875 | 2,875 | 0 to 2.9 K |
| Mar 12 2020 | CRTX | Cortexyme, Inc. | RYAN UNA S | Director | Buy | P | 17.00 | 2,875 | 48,875 | 2,875 | 0 to 2.9 K |
| Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 18.41 | 9,358 | 172,281 | 9,358 | |
| Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 0.00 | 3,802 | 0 | 46,845 | 43 K to 46.8 K (+8.83 %) |
| Oct 06 2016 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | M | 11.83 | 5,000 | 59,150 | 0 | |
| Oct 06 2016 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Payment of Exercise | F | 16.91 | 3,498 | 59,151 | 43,043 | 46.5 K to 43 K (-7.52 %) |
| Oct 06 2016 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Buy | M | 11.83 | 5,000 | 59,150 | 46,541 | 41.5 K to 46.5 K (+12.04 %) |
| Jun 16 2016 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 14.82 | 4,048 | 59,991 | 41,541 | 37.5 K to 41.5 K (+10.80 %) |
| Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 15.77 | 6,540 | 103,136 | 6,540 | |
| Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 15.77 | 2,854 | 45,008 | 37,493 | 34.6 K to 37.5 K (+8.24 %) |
| Jun 15 2015 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 19.98 | 1,126 | 22,497 | 34,639 | 33.5 K to 34.6 K (+3.36 %) |
| Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Option Exercise | A | 17.05 | 6,881 | 117,321 | 6,881 | |
| Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | RYAN UNA S | Director | Grant | A | 17.05 | 2,639 | 44,995 | 33,513 | 30.9 K to 33.5 K (+8.55 %) |
| Mar 11 2008 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Option Exercise | A | 8.16 | 612,500 | 4,998,000 | 612,500 | |
| Jul 02 2007 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Buy | L | 0.71 | 500 | 353 | 899,213 | 898.7 K to 899.2 K (+0.06 %) |
| Jan 08 2007 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Option Exercise | A | 1.36 | 50,000 | 67,750 | 1,060,000 | |
| Aug 16 2006 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Buy | P | 1.36 | 30,300 | 41,057 | 898,713 | 868.4 K to 898.7 K (+3.49 %) |
| Jul 03 2006 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Buy | L | 1.37 | 500 | 685 | 868,413 | 867.9 K to 868.4 K (+0.06 %) |
| Jan 05 2006 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Buy | L | 1.04 | 500 | 519 | 867,913 | 867.4 K to 867.9 K (+0.06 %) |
| Sep 23 2005 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Grant | A | 0.00 | 200,000 | 0 | 1,067,413 | 867.4 K to 1.1 M (+23.06 %) |
| Jan 04 2005 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Buy | L | 1.71 | 500 | 855 | 867,413 | 866.9 K to 867.4 K (+0.06 %) |
| Nov 09 2004 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Grant | A | 0.00 | 400,000 | 0 | 866,913 | 466.9 K to 866.9 K (+85.67 %) |
| Aug 04 2004 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Buy | P | 1.88 | 5,701 | 10,718 | 466,913 | 461.2 K to 466.9 K (+1.24 %) |
| Aug 04 2004 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Buy | P | 1.87 | 1,423 | 2,661 | 461,212 | 459.8 K to 461.2 K (+0.31 %) |
| Aug 04 2004 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Buy | P | 1.86 | 1,200 | 2,232 | 459,789 | 458.6 K to 459.8 K (+0.26 %) |
| Aug 04 2004 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Buy | P | 1.85 | 1,400 | 2,590 | 458,589 | 457.2 K to 458.6 K (+0.31 %) |
| Aug 04 2004 | AVAN | Celldex Therapeuti ... | RYAN UNA S | President & CEO | Buy | P | 1.84 | 276 | 508 | 457,189 | 456.9 K to 457.2 K (+0.06 %) |
Page: 1